Travis Afb, CANCT06911359Now EnrollingIRB Ready

Knee Osteoarthritis (OA) Clinical Trial in Travis Afb, CA

Access cutting-edge knee osteoarthritis (oa) treatment through this clinical trial at a research site in Travis Afb. Study-provided care at no cost to qualified participants.

Sponsored by David Grant U.S. Air Force Medical Center

Quick Self-Assessment

See if you qualify for this Travis Afb location

Preparing your pre-screening questions…

Expert Care in Travis Afb

Access knee osteoarthritis (oa) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related knee osteoarthritis (oa) treatment provided free

Apply for This Travis Afb Location

Check if you qualify for this knee osteoarthritis (oa) clinical trial in Travis Afb, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Travis Afb

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Travis Afb site if eligible
  4. 4Begin participation

About This Knee Osteoarthritis (OA) Study in Travis Afb

Our purpose is to expand upon the results of the pilot study performed at David Grant Medical Center (DGMC) which showed that concomitant non-steroidal NSAID use in adults with knee osteoarthritis (OA) undergoing a three-shot dextrose prolotherapy (DPT) injection series did not negate the efficacy of DPT. Additionally, it showed that giving both treatments simultaneously is safe and efficacious. The small sample size and design of the pilot study limited the conclusions that can be drawn on the concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) during DPT treatment. This is a double-blinded, randomized, controlled trial that includes a subject population of males and females between the ages of 45-75 years who are DoD beneficiaries empaneled at DGMC with a history of chronic, symptomatic knee osteoarthritis in one or both knees, that meet study criteria. Participants will have study inclusion/exclusion and knee films (within the past 2 years) reviewed by a study investigator to confirm eligibility to participate in the study. Eligible participants will be consented then randomized into treatment groups (ibuprofen, placebo) by the pharmacy. Participants will provide a baseline assessment of pain and dysfunction using the Numeric Pain Rating Scale (NPRS) and Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaires. Participants will then have a series of three injections of 4mL of 25% dextrose mixed with 1% lidocaine into the knee under ultrasound guidance, performed at 0, 4 and 8 weeks (+/- 1 week) in addition to a 7-day supply of the study drug (ibuprofen, placebo) at these time points. NPRS and KOOS scores will be collected at 0, 4, 8 and 12 weeks. During the study period, participants will be counseled to avoid oral analgesics (other than what has been prescribed for them as part of the study) including NSAIDs, acetaminophen, or opioids, in addition to other procedures to treat their knee pain to include other injections, acupuncture, physical therapy, and surgery. The primary outcome is to determine the effect of concomitant oral ibuprofen vs. placebo use on intra-articular knee injections using hypertonic dextrose and the determine the short and long-term outcomes in each treatment group (ibuprofen, placebo) using the NPRS and KOOS questionnaires to assess pain and function.

Sponsor: David Grant U.S. Air Force Medical Center

Who Can Participate

Inclusion Criteria

Must be DoD Healthcare beneficiaries empaneled at DGMC
Adults aged 45-75 years with a clinical diagnosis of Knee OA (either unilateral or bilateral) based on clinical and radiographic criteria as defined by the American College of Rheumatology (Altman 1987)
Knee radiographs (within 2 years of start date) with Kellgren-Lawrence classification of 2-3
Moderate to severe Knee pain for at least 3 months defined as a score of ≥4 using the NPRS (0-10) in response to the question "What is the average level of your left/ right knee pain in the past 3 months?"
English speaking
Not pregnant
Not breastfeeding
No allergy to dextrose, lidocaine, or sulfite

Exclusion Criteria

Previous knee replacement surgery
Previous meniscus repair/debridement surgery or chondral replacement surgery
Any intra-articular injection including steroid, prolotherapy or platelet rich plasms within the previous 3 months
Significant effusion as defined by a ballotable patella
Pregnancy or breastfeeding
Current/ongoing medical problems obtained from chart review contraindicating NSAID use to include chronic kidney disease stage II or higher, acute interstitial nephritis, coronary artery disease requiring percutaneous coronary intervention (PCI) or bypass surgery; Major Adverse Coronary Event (MACE), body mass index (BMI) ≥40, inflammatory arthropathy (gouty arthritis, psoriatic arthritis, or septic arthritis), history of GI bleed.
Non-English speaking
Allergy to dextrose, lidocaine, or sulfite

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Travis Afb?

Yes, this clinical trial (NCT06911359) has an active research site in Travis Afb, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Knee Osteoarthritis (OA) Treatment Options in Travis Afb, CA

If you're searching for knee osteoarthritis (oa) treatment options in Travis Afb, CA, this clinical trial (NCT06911359) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Travis Afb research site is actively enrolling participants for this clinical trial. You'll receive care from experienced knee osteoarthritis (oa) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all knee osteoarthritis (oa) clinical trials near you to find additional studies recruiting in your area.

More Osteoarthritis Trials in Travis Afb, CA

See all osteoarthritis clinical trials recruiting in Travis Afb — not just this study.

Browse Osteoarthritis Trials in Travis Afb

Browse More Trials by Condition

Ready to Join in Travis Afb?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Travis Afb, CA